Wolfe Michael S
Center for Neurologic Diseases, Brigham and Women's Hospital, 77 Avenue Louis Pasteur, HIM 754, Boston, Massachusetts 02115, USA.
Nat Rev Drug Discov. 2002 Nov;1(11):859-66. doi: 10.1038/nrd938.
Alzheimer's disease is a progressive and ultimately fatal neurological disorder for which there is no effective treatment at present. The disease is characterized pathologically by cerebral plaques that contain the amyloid-beta peptide and thread-like neuronal structures composed of the microtubule-associated protein TAU. Both amyloid-beta and TAU are thought to be crucial to pathogenesis, but compelling evidence supports amyloid-beta as the 'prime mover'. The main efforts for developing therapeutics are therefore focused on preventing amyloid-beta production, aggregation or downstream neurotoxic events. The progress of these and other approaches raises the hope that effective agents for the prevention and treatment of Alzheimer's disease will be available in the near future.
阿尔茨海默病是一种进行性且最终致命的神经疾病,目前尚无有效治疗方法。该疾病的病理特征是脑内出现含有β-淀粉样肽的斑块以及由微管相关蛋白TAU组成的丝状神经元结构。β-淀粉样蛋白和TAU都被认为对发病机制至关重要,但有力证据支持β-淀粉样蛋白是“主要推动者”。因此,开发治疗方法的主要努力集中在预防β-淀粉样蛋白的产生、聚集或下游神经毒性事件。这些及其他方法的进展带来了希望,即在不久的将来会有预防和治疗阿尔茨海默病的有效药物。